Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis-Reference-Cited by-同舟云学术

Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis

Published:2020-10 Issue: Volume:172 Page:106134
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Xing Xiaojing,Li Anqi,Li Chengxin

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference22 articles.

1. Association of dermatomyositis with systemic and opportunistic infections in the United States;Ren;Arch. Dermatol. Res.,2019

2. Interstitial lung disease in polymyositis and dermatomyositis;Long;Clin. Chest Med.,2019

3. Predictive factors for sustained remission with stratification by myositis-specific autoantibodies in adult polymyositis/dermatomyositis;Watanabe;Rheumatology,2020

4. Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody-positive inflammatory myositis;Abe;Rheumatology,2017

5. Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances;Hallowell;Curr. Opin. Rheumatol.,2014

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of cardiovascular disease risk with coronary artery calcification and thoracic aortic dilation: a study in idiopathic inflammatory myopathies and systemic lupus erythematosus;Clinical Rheumatology;2024-08-26

2. Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy;Arthritis Research & Therapy;2024-08-22

3. Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases;Frontiers in Immunology;2024-08-06

4. A single-centre study on abnormal antinuclear antibodies in children caused by intravenous infusion of gamma globulin;Frontiers in Immunology;2024-07-18

5. Prognostic analysis of MDA5‐associated clinically amyopathic dermatomyositis with interstitial lung disease;Immunity, Inflammation and Disease;2024-06